Skip to main content
Figure 4 | Radiation Oncology

Figure 4

From: Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia

Figure 4

Parotid gland overdose assessment: Difference between the mean cumulated dose (without replanning) and the mean dose at the planning, in each of the parotid gland, for each of the 15 patients ( 4 a). The corresponding impact on the xerostomia risk (%) is presented Figure 4 b. NTCP: normal tissue complication risk of xerostomia defined as a salivary flow ratio <25% of the pretreatment one [21].

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us